Literature DB >> 16719633

Differences in patterns of symptom attribution in diagnosing schizophrenia between African American and non-African American clinicians.

Steven J Trierweiler1, Harold W Neighbors, Cheryl Munday, Estina E Thompson, James S Jackson, Victoria J Binion.   

Abstract

The authors examined clinician race differences in symptom attribution patterns in diagnosing psychiatric inpatients from a low-income, African American community. Different decision models were applied to patients based on clinician race. African American clinicians diagnosed schizophrenia with higher odds than non-African American clinicians when they believed hallucinations were present and avoided that diagnosis with lower odds when they considered substance abuse issues. Non-African American clinicians usually related the attribution of negative symptoms to the diagnosis of schizophrenia while African American clinicians did not make this linkage. The study highlights the need for more detailed examination of cultural influences on diagnostic judgments. Copyright 2006 APA, all rights reserved.

Entities:  

Mesh:

Year:  2006        PMID: 16719633     DOI: 10.1037/0002-9432.76.2.154

Source DB:  PubMed          Journal:  Am J Orthopsychiatry        ISSN: 0002-9432


  12 in total

1.  Racial comparison of therapeutic support, service use, and satisfaction among male outpatients with severe mental illness.

Authors:  Jack Tsai; Rani A Desai; Robert A Rosenheck
Journal:  Psychiatr Q       Date:  2012-12

2.  Ethnicity effects on clinical diagnoses compared to best-estimate research diagnoses in patients with psychosis: a retrospective medical chart review.

Authors:  Deidre M Anglin; Dolores Malaspina
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

3.  Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing.

Authors:  Kathleen Askland; Cynthia Read; Chloe O'Connell; Jason H Moore
Journal:  Hum Genet       Date:  2011-08-25       Impact factor: 4.132

4.  An exploration of how psychotic-like symptoms are experienced, endorsed, and understood from the National Latino and Asian American Study and National Survey of American Life.

Authors:  Tara R Earl; Lisa Roxanne Fortuna; Shan Gao; David R Williams; Harold Neighbors; David Takeuchi; Margarita Alegría
Journal:  Ethn Health       Date:  2014-06-12       Impact factor: 2.772

Review 5.  Racial disparities in psychotic disorder diagnosis: A review of empirical literature.

Authors:  Robert C Schwartz; David M Blankenship
Journal:  World J Psychiatry       Date:  2014-12-22

6.  Interviewer-perceived honesty as a mediator of racial disparities in the diagnosis of schizophrenia.

Authors:  Shaun M Eack; Amber L Bahorik; Christina E Newhill; Harold W Neighbors; Larry E Davis
Journal:  Psychiatr Serv       Date:  2012-09-01       Impact factor: 3.084

7.  Clinical and psychosocial outcomes of Black Americans in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) study.

Authors:  Kim T Mueser; David L Penn; Arundati Nagendra; David M Weiss; Carrington Merritt; Corinne Cather; Effua E Sosoo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-08-06       Impact factor: 4.519

8.  Race and self-reported paranoia: Increased item endorsement on subscales of the SPQ.

Authors:  J Wolny; Alexandra B Moussa-Tooks; Allen J Bailey; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Res       Date:  2021-12-09       Impact factor: 4.662

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

Review 10.  Ethnicity and variability of psychotic symptoms.

Authors:  William A Vega; Roberto Lewis-Fernández
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.